Clinical Trials Browser

Phase 1 × INDUSTRY × margetuximab × Clear all

Breast Neoplasms, Stomach Neoplasms

NCT03219268 2023-12-21

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

BreastGastrointestinalGynecologicHead & NeckOther hematologic neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Ovarian Neoplasms, Cholangiocarcinoma, Hematologic Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Clinical Trials

Safety Study of MGAH22 in HER2-positive Carcinomas

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms